These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


321 related items for PubMed ID: 6869590

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endogenous modulation of monoamine oxidase in schizophrenic and normal humans.
    Becker RE, Giambalvo CT.
    Am J Psychiatry; 1982 Dec; 139(12):1567-70. PubMed ID: 7149055
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Delusional misidentification and platelet monoamine oxidase.
    Barton JL, Chaparala S, Barton ES, Jackson IV, Davis LG.
    Biol Psychiatry; 1980 Apr; 15(2):275-82. PubMed ID: 7417616
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Platelet monoamine oxidase: studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groups.
    Wise CD, Bridge TP, Potkin SG, Wyatt RJ.
    Psychiatry Res; 1979 Oct; 1(2):187-90. PubMed ID: 298348
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Platelet monoamine oxidase and plasma amine oxidase in psychiatric patients.
    Meltzer HY, Arora RC, Jackman H, Pscheidt G, Smith MD.
    Schizophr Bull; 1980 Oct; 6(2):213-9. PubMed ID: 7375852
    [Abstract] [Full Text] [Related]

  • 15. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
    Spivak B, Kosower N, Zipser Y, Shreiber-Schul N, Apter A, Tyano S, Weizman A.
    Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE, Wise CD, Potkin SG, Zalcman S, Phelps BH, Lovenberg W, Wyatt RJ.
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [Abstract] [Full Text] [Related]

  • 18. Platelet MAO Vmax and Km in chronic schizophrenic subjects.
    Giller EL, Bierer L, Rubinow D, Docherty JP.
    Am J Psychiatry; 1980 Jan; 137(1):97-8. PubMed ID: 7352569
    [No Abstract] [Full Text] [Related]

  • 19. Platelet monoamine oxidase activity in the psychoses: relationship to symptoms and lithium response.
    Hitzemann RJ, Sautter F, Hitzemann B, Hirschowitz J, Garver DL.
    Psychiatry Res; 1984 Mar; 11(3):211-21. PubMed ID: 6587414
    [Abstract] [Full Text] [Related]

  • 20. Decreased blood platelet MAO activity in unmedicated chronic schizophrenic patients.
    Domino EF, Khanna SS.
    Am J Psychiatry; 1976 Mar; 133(3):323-6. PubMed ID: 943955
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.